The present invention is directed to a compound of 2-N halo-4-methylsulfonyl-butyric acid, such as 2-N chloro-4-methylsulfonyl-butyric acid, or a pharmaceutically acceptable salt or solvate thereof. The second controllable switch is a PMOS-FET. The cell sealing material is composed of ceramic particles and an assistant for fluidizing the ceramic particles.